Effectiveness assessment of riluzole in the prevention of oxaliplatin-induced peripheral neuropathy: A phase II randomized study by the UNICANCER with cooperation of AFSOS.
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 06 Nov 2018
At a glance
- Drugs Riluzole (Primary)
- Indications Peripheral neuropathies
- Focus Therapeutic Use
- Acronyms RILUZOX-01
- 26 Oct 2018 Planned End Date changed from 18 Jan 2022 to 31 Aug 2022.
- 17 Sep 2018 New trial record